BBI Life: Privatisation Offer For DNA Synthesizer
Following a brief trading halt, BBI Life Sciences (1035 HK), the biggest supplier of DNA synthesis products in the PRC, announced a privatisation...
730 Views
Wuxi Biologics Placement - Probably Not a Surprise to Sell Again when Lock-Up Expires
Biologics Holdings is looking to sell 50m shares of WuXi Biologics (Cayman) Inc. (2269 HK) worth about US$500m. Post sale, Biologics Holdings will...
620 Views
Genscript Biotech Placement - Raising Money to Build Up CAR-T R&D and Production Facilities
Genscript Biotech Corp (1548 HK) is looking to raise US$304m by selling 90m shares (including 15m top-up primary shares). This is a concurrent...
268 Views
Genscript Biotech IPO - Financial Track Record Doesn't Inspire Much Confidence
Genscript Biotech (GS) plans to raise US$70-90m through its IPO. This is a follow up note to Kemp Dolliver, CFA 's insight An Intriguing Small Cap...
506 Views
An Intriguing Small Cap with Price Risk
SummaryGenscript Biotech (1548 HK) is a pending small cap healthcare IPO. We think Genscript is a very interesting company because of its leading...
426 Views